EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 100 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,140 | -57.6% | 3,737 | -2.1% | 0.00% | – |
| Q2 2023 | $2,689 | -12.7% | 3,819 | +11.1% | 0.00% | – |
| Q1 2023 | $3,081 | -77.7% | 3,436 | -70.6% | 0.00% | – |
| Q4 2022 | $13,798 | -56.9% | 11,693 | +178.6% | 0.00% | – |
| Q3 2022 | $32,000 | -36.0% | 4,197 | -46.9% | 0.00% | – |
| Q2 2022 | $50,000 | 0.0% | 7,904 | +29.8% | 0.00% | – |
| Q1 2022 | $50,000 | -33.3% | 6,088 | -57.9% | 0.00% | – |
| Q4 2021 | $75,000 | +13.6% | 14,458 | +45.7% | 0.00% | – |
| Q3 2021 | $66,000 | 0.0% | 9,921 | +26.9% | 0.00% | – |
| Q2 2021 | $66,000 | -8.3% | 7,815 | -4.5% | 0.00% | – |
| Q1 2021 | $72,000 | -90.9% | 8,179 | -87.3% | 0.00% | – |
| Q4 2020 | $791,000 | +61.8% | 64,316 | +7.1% | 0.00% | – |
| Q3 2020 | $489,000 | -15.8% | 60,027 | -0.9% | 0.00% | – |
| Q2 2020 | $581,000 | +34.5% | 60,556 | -4.7% | 0.00% | – |
| Q1 2020 | $432,000 | +332.0% | 63,553 | +844.0% | 0.00% | – |
| Q4 2019 | $100,000 | +426.3% | 6,732 | +247.2% | 0.00% | – |
| Q3 2019 | $19,000 | -75.0% | 1,939 | -73.3% | 0.00% | – |
| Q2 2019 | $76,000 | -80.7% | 7,267 | -74.2% | 0.00% | – |
| Q1 2019 | $394,000 | +39300.0% | 28,164 | +21075.9% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 133 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 133 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 133 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 133 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | +100.0% | 133 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 133 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -75.0% | 133 | -57.4% | 0.00% | – |
| Q1 2017 | $4,000 | +100.0% | 312 | +129.4% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 136 | +2.3% | 0.00% | – |
| Q3 2016 | $2,000 | -81.8% | 133 | -74.7% | 0.00% | – |
| Q2 2016 | $11,000 | +266.7% | 526 | +200.6% | 0.00% | – |
| Q1 2016 | $3,000 | – | 175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |